TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Estrella Immunopharma (ESLA).
Estrella Immunopharma, Inc. has appointed Ms. Hong Zhang as the new Chairperson and member of the Board of Directors, expanding the board to six members. The CEO, Dr. Cheng Liu, will remain on the board while Ms. Zhang will be compensated for her roles and reimbursed for expenses. Estrella is also negotiating a Consulting Agreement with Ms. Zhang’s company for strategic initiatives in Asia. Details of the agreement are pending audit committee approval. The company’s press release about these changes is not considered filed for regulatory purposes but is provided for informational use.
See more data about ESLA stock on TipRanks’ Stock Analysis page.